About

Tom Lawrie-Fussey was Head of Digital Health at Cambridge Design Partnership until 2019, and has more than 15 years’ product development experience and is a Chartered Engineer with a master’s degree. He has been trusted by a myriad of well-known brands during his career, spanning automotive, industrial, FMCG, consumer healthcare and drug delivery.

Advising on connectivity and digital services, Mr Lawrie-Fussey led the development of a number of digital toolkits to help clients to de-risk their digital innovation. One of these, the instrumented user-insights service “diialog™” has grown to serve multiple markets, with various ongoing client projects helping to steer and inform product development investment.

Contributions

EXPERT VIEW

HOW A DIGITAL APPROACH CAN UNPICK CLINICAL TRIAL CHALLENGES AND IMPROVE OUTCOMES

Matt Ash, Tom Lawrie-Fussey and Bastiaan De Leeuw look at the role digital technology can play in the development of drug-device combination products.

More contributions

EXPERT VIEW

WE’RE OFF TO SEE THE WIZARD: “USE-LIKE” PROTOTYPING OF DIGITAL CONCEPTS

Tom Lawrie-Fussey and Lucy Sheldon introduce “Wizard of Oz” testing, named after the classic novel and film, whereby experimenters can field test concepts at a very early stage by giving the illusion of a finished product, saving potential costly and time-consuming changes further along the development process.

EXPERT VIEW

THE SMART APPROACH TO HARNESSING DATA

As the drug delivery world moves to embrace big data, it is important to remember that unseen risks await the unwary. Tom Lawrie-Fussey explains further.

EXPERT VIEW

THE LATEST DIGITAL TOOLS REVEAL ACTUAL PATIENT BEHAVIOUR

Ryan Noble and Tom Lawrie-Fussey discuss the potential of digital innovations to improve understanding of real patient behaviour and consequently increase adherence.